Which is the better prognostic factor for resected non-small cell lung cancer: The number of metastatic lymph nodes or the currently used nodal stage classification?

Shenhai Wei, Hisao Asamura, Riken Kawachi, Hiroyuki Sakurai, Shun Ichi Watanabe

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

This retrospective study was conducted to evaluate the prognostic significance of the number of metastatic lymph nodes (nN) in resected non-small cell lung cancer (NSCLC) in comparison with the currently used pathologic nodal (pN) category in the staging system. Methods: A total of 1659 patients who underwent potentially curative resection for NSCLC from 2000 to 2006 were included in this study. The association between the nN and survival was explored, and the results were compared with those using the location-based pN stage classification. Results: The patients were divided into four categories according to the number of metastatic nodes: nN0, absence of metastatic nodes; nN1, metastasis in one to two nodes; nN2, metastasis in three to six nodes; and nN3, metastasis in seven or more nodes. The 5-year overall survival for nN0, nN1, nN2, and nN3 was 89.2%, 65.1%, 42.1%, and 22.4%, respectively (p < 0.001). The nN category could be used to subdivide pN1 and pN2 patients into two (nN1 and nN2) and three (nN1, nN2, and nN3) prognostically distinct subgroups, respectively. Multivariate analysis showed the nN category was an independent prognostic factor for resected NSCLC. The difference in overall survival between pN1 and pN2 was not significant (55.4% versus 47.8%, p = 0.245). Patients in each nN category could not be subdivided into different prognostic subgroups according to the pN classification. Conclusions: The nN category in this study was shown to be a better prognostic determinant than the location-based pN stage classification.

Original languageEnglish
Pages (from-to)310-318
Number of pages9
JournalJournal of Thoracic Oncology
Volume6
Issue number2
DOIs
Publication statusPublished - 2011 Feb
Externally publishedYes

Fingerprint

Non-Small Cell Lung Carcinoma
Lymph Nodes
Neoplasm Metastasis
Survival
Multivariate Analysis
Retrospective Studies

Keywords

  • Lymph node metastasis
  • Non-small cell lung cancer
  • Prognosis

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Which is the better prognostic factor for resected non-small cell lung cancer : The number of metastatic lymph nodes or the currently used nodal stage classification? / Wei, Shenhai; Asamura, Hisao; Kawachi, Riken; Sakurai, Hiroyuki; Watanabe, Shun Ichi.

In: Journal of Thoracic Oncology, Vol. 6, No. 2, 02.2011, p. 310-318.

Research output: Contribution to journalArticle

@article{0d05d19fda12443dba7cf8526b9d96f1,
title = "Which is the better prognostic factor for resected non-small cell lung cancer: The number of metastatic lymph nodes or the currently used nodal stage classification?",
abstract = "This retrospective study was conducted to evaluate the prognostic significance of the number of metastatic lymph nodes (nN) in resected non-small cell lung cancer (NSCLC) in comparison with the currently used pathologic nodal (pN) category in the staging system. Methods: A total of 1659 patients who underwent potentially curative resection for NSCLC from 2000 to 2006 were included in this study. The association between the nN and survival was explored, and the results were compared with those using the location-based pN stage classification. Results: The patients were divided into four categories according to the number of metastatic nodes: nN0, absence of metastatic nodes; nN1, metastasis in one to two nodes; nN2, metastasis in three to six nodes; and nN3, metastasis in seven or more nodes. The 5-year overall survival for nN0, nN1, nN2, and nN3 was 89.2{\%}, 65.1{\%}, 42.1{\%}, and 22.4{\%}, respectively (p < 0.001). The nN category could be used to subdivide pN1 and pN2 patients into two (nN1 and nN2) and three (nN1, nN2, and nN3) prognostically distinct subgroups, respectively. Multivariate analysis showed the nN category was an independent prognostic factor for resected NSCLC. The difference in overall survival between pN1 and pN2 was not significant (55.4{\%} versus 47.8{\%}, p = 0.245). Patients in each nN category could not be subdivided into different prognostic subgroups according to the pN classification. Conclusions: The nN category in this study was shown to be a better prognostic determinant than the location-based pN stage classification.",
keywords = "Lymph node metastasis, Non-small cell lung cancer, Prognosis",
author = "Shenhai Wei and Hisao Asamura and Riken Kawachi and Hiroyuki Sakurai and Watanabe, {Shun Ichi}",
year = "2011",
month = "2",
doi = "10.1097/JTO.0b013e3181ff9b45",
language = "English",
volume = "6",
pages = "310--318",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "2",

}

TY - JOUR

T1 - Which is the better prognostic factor for resected non-small cell lung cancer

T2 - The number of metastatic lymph nodes or the currently used nodal stage classification?

AU - Wei, Shenhai

AU - Asamura, Hisao

AU - Kawachi, Riken

AU - Sakurai, Hiroyuki

AU - Watanabe, Shun Ichi

PY - 2011/2

Y1 - 2011/2

N2 - This retrospective study was conducted to evaluate the prognostic significance of the number of metastatic lymph nodes (nN) in resected non-small cell lung cancer (NSCLC) in comparison with the currently used pathologic nodal (pN) category in the staging system. Methods: A total of 1659 patients who underwent potentially curative resection for NSCLC from 2000 to 2006 were included in this study. The association between the nN and survival was explored, and the results were compared with those using the location-based pN stage classification. Results: The patients were divided into four categories according to the number of metastatic nodes: nN0, absence of metastatic nodes; nN1, metastasis in one to two nodes; nN2, metastasis in three to six nodes; and nN3, metastasis in seven or more nodes. The 5-year overall survival for nN0, nN1, nN2, and nN3 was 89.2%, 65.1%, 42.1%, and 22.4%, respectively (p < 0.001). The nN category could be used to subdivide pN1 and pN2 patients into two (nN1 and nN2) and three (nN1, nN2, and nN3) prognostically distinct subgroups, respectively. Multivariate analysis showed the nN category was an independent prognostic factor for resected NSCLC. The difference in overall survival between pN1 and pN2 was not significant (55.4% versus 47.8%, p = 0.245). Patients in each nN category could not be subdivided into different prognostic subgroups according to the pN classification. Conclusions: The nN category in this study was shown to be a better prognostic determinant than the location-based pN stage classification.

AB - This retrospective study was conducted to evaluate the prognostic significance of the number of metastatic lymph nodes (nN) in resected non-small cell lung cancer (NSCLC) in comparison with the currently used pathologic nodal (pN) category in the staging system. Methods: A total of 1659 patients who underwent potentially curative resection for NSCLC from 2000 to 2006 were included in this study. The association between the nN and survival was explored, and the results were compared with those using the location-based pN stage classification. Results: The patients were divided into four categories according to the number of metastatic nodes: nN0, absence of metastatic nodes; nN1, metastasis in one to two nodes; nN2, metastasis in three to six nodes; and nN3, metastasis in seven or more nodes. The 5-year overall survival for nN0, nN1, nN2, and nN3 was 89.2%, 65.1%, 42.1%, and 22.4%, respectively (p < 0.001). The nN category could be used to subdivide pN1 and pN2 patients into two (nN1 and nN2) and three (nN1, nN2, and nN3) prognostically distinct subgroups, respectively. Multivariate analysis showed the nN category was an independent prognostic factor for resected NSCLC. The difference in overall survival between pN1 and pN2 was not significant (55.4% versus 47.8%, p = 0.245). Patients in each nN category could not be subdivided into different prognostic subgroups according to the pN classification. Conclusions: The nN category in this study was shown to be a better prognostic determinant than the location-based pN stage classification.

KW - Lymph node metastasis

KW - Non-small cell lung cancer

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=79551545979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551545979&partnerID=8YFLogxK

U2 - 10.1097/JTO.0b013e3181ff9b45

DO - 10.1097/JTO.0b013e3181ff9b45

M3 - Article

C2 - 21206387

AN - SCOPUS:79551545979

VL - 6

SP - 310

EP - 318

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 2

ER -